CHROMagar Company Profile

14:44 EDT 24th June 2018 | BioPortfolio

CHROMagar was founded by Dr. Alain Rambach, an internationally recognized microbiologist and pioneer in the field of chromogenic media for the detection of pathogenic microorganisms. Engaged in genetic engineering research as early as 1974, he developed the first E.coli chromogenic detection media, filing the patent in 1979. Several years later, he invented the Rambach Agar for the detection of Salmonella, now distributed world-wide by one of the world's major pharmaceutical groups.
These successes led to the creation of the firm CHROMagar. Front runner in the area of innovative media, CHROMagar's mission is to develop and commercialize the products of Dr. Rambach's current research - new first generation chromogenic media and second generation (multicolor) chromogenic media.



News Articles [0 Results]


Drugs and Medications [0 Results]


PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

CHROMagar mSuperCARBA and RAPIDEC® Carba NP test for detection of carbapenemase-producing Enterobacteriaceae.

A novel chromogenic medium CHROMagar mSuperCARBA was evaluated to detect carbapenem-resistant Gram-negatives. This medium is as sensitive and as specific as the SUPERCARBA medium for detecting KPC, MB...

Tellurite resistance profiles and performance of different chromogenic agars for detection of non-O157 Shiga toxin-producing Escherichia coli.

Shiga toxin-producing Escherichia coli (STEC) are globally important food-borne pathogens. The isolation of non-O157 STEC is a significant public health challenge due to the dramatic diversity of thei...

Chromogenic culture media or rapid immunochromatographic test: Which is better for detecting Klebsiella pneumoniae that produce OXA-48 and can they be used in blood and urine specimens.

Our goal was to compare a rapid test (OXA-48K-SeT) and four different chromogenic media (CHROMagar KPC, CHROMagar mSuperCARBA, ChromID Carba and ChromID OXA-48) for the detection of OXA-48 producing K...

Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.

Candida auris is an emerging yeast pathogen of global significance. Its multidrug-resistant nature and inadequacies of conventional identification systems pose diagnostic and therapeutic challenges. T...

Evaluation of the frequency of Candida spp. in hospitalized and non-hospitalized subjects.

The aim of this study was to evaluate the frequency of Candida species between a non-hospitalized and a hospitalized population. For this purpose, samples of saliva were sampled through sterile swabs,...

Clinical Trials [3 Associated Clinical Trials listed on BioPortfolio]

Candida Albicans in Periodontal and Endodontic Lesions in Diabetic and Normoglycemic Patients

Pulpal and periodontal tissues are closely related and have similar microbiota that cross-contamination between the pulp and periodontal tissues.The aim of this study was to investigate th...

Clinical Trial to Reduce Antibiotic Resistance in European Intensive Cares

Colonization of patients with Antimicrobial Resistant Bacteria (AMRB) like Methicillin Resistant Staphylococcus Aureus (MRSA), Vancomycin-Resistant Enterococcus (VRE) and Extended-Spectrum...

Clinical and Laboratorial Evaluation of the Desinfection Solutions in Candida Species From Total Prostheses and Palate of Total Edentulous.

This clinical study identified the Candida species from the palate and complete dentures of edentulous individuals with prostheses-related stomatitis (PRS) and evaluated the effect of disi...

Companies [1 Associated Companies listed on BioPortfolio]


CHROMagar was founded by Dr. Alain Rambach, an internationally recognized microbiologist and pioneer in the field of chromogenic media for the detection of pathogenic microorganisms. Engaged in geneti...

More Information about "CHROMagar" on BioPortfolio

We have published hundreds of CHROMagar news stories on BioPortfolio along with dozens of CHROMagar Clinical Trials and PubMed Articles about CHROMagar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of CHROMagar Companies in our database. You can also find out about relevant CHROMagar Drugs and Medications on this site too.

Quick Search


Relevant Topic

Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Corporate Database Quicklinks

Searches Linking to this Company Record